Literature DB >> 26747761

Predictive Value of Outer Retina En Face OCT Imaging for Geographic Atrophy Progression.

Audrey Giocanti-Auregan1, Ramin Tadayoni2, Franck Fajnkuchen3, Pauline Dourmad4, Stéphanie Magazzeni5, Salomon Y Cohen6.   

Abstract

PURPOSE: We determined if the ellipsoid zone (EZ) disruption pattern could be predictive of the geographic atrophy (GA) pattern at 1 year in dry age-related macular degeneration (AMD).
METHODS: A retrospective study was done of dry eyes in patients with AMD and GA from July to November 2013. Eyes with previous choroidal neovascularization were excluded. Based on spectral domain optical coherence tomography (SD-OCT), the GA was assessed at each timepoint, using a sub-RPE slab derived from the Cirrus Advanced RPE Analysis software encompassing the RPE (sub-RPE slab). Disruption of the EZ also was assessed at baseline, using en face extraction of a 20-μm-thick slab, 20 μm above the RPE (EZ slab) encompassing the EZ band using two different algorithms (RPE and RPE-fit). The EZ disruption area surrounding GA at baseline was quantified using ImageJ software. Primary endpoint was to identify en face pattern similarities between the baseline EZ disruption and the 1-year GA. Secondary endpoint was to correlate the baseline EZ disruption area surrounding GA with the GA enlargement over 1 year. Statistical analysis was performed using a correlation test (Pearson) and a t-test.
RESULTS: We included 37 eyes of 31 patients with dry AMD. En face EZ disruption pattern correlated in two-thirds of cases with the 1-year GA pattern using both algorithms. The EZ disruption area surrounding GA at baseline and GA enlargement over 1 year were poorly correlated when RPE-fit algorithm (R = 0.17) was used. The correlation was still poor using an RPE algorithm (R = 0.38), but increased after selection of eyes without reticular pseudodrusen (R = 0.79).
CONCLUSIONS: The EZ disruption pattern could be an indicator for GA pattern progression, but is not a good quantitative tool to predict the size of GA in the overall population over a 1-year period except for patients without reticular pseudodrusen. The results in this specific population must be confirmed by further studies.

Entities:  

Mesh:

Year:  2015        PMID: 26747761     DOI: 10.1167/iovs.14-15480

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Developing a potential retinal OCT biomarker for local growth of geographic atrophy.

Authors:  Yue Yu; Eric M Moult; Siyu Chen; Qiushi Ren; Philip J Rosenfeld; Nadia K Waheed; James G Fujimoto
Journal:  Biomed Opt Express       Date:  2020-08-20       Impact factor: 3.732

2.  Automatic Quantification Software for Geographic Atrophy Associated with Age-Related Macular Degeneration: A Validation Study.

Authors:  José M Ruiz-Moreno; Jorge Ruiz-Medrano; Francisco Lugo; Belen Sirvent; Ignacio Flores-Moreno
Journal:  J Ophthalmol       Date:  2020-08-05       Impact factor: 1.909

3.  Early Detection of Incipient Retinal Pigment Epithelium Atrophy Overlying Drusen with Fundus Autofluorescence vs. Spectral Domain Optical Coherence Tomography.

Authors:  Anabel Rodríguez; Marc Biarnés; Rosa M Coco-Martin; Anna Sala-Puigdollers; Jordi Monés
Journal:  J Ophthalmol       Date:  2020-09-16       Impact factor: 1.909

Review 4.  Spotlight on reticular pseudodrusen.

Authors:  Alessandro Rabiolo; Riccardo Sacconi; Maria Vittoria Cicinelli; Lea Querques; Francesco Bandello; Giuseppe Querques
Journal:  Clin Ophthalmol       Date:  2017-09-20

5.  Validating Ellipsoid Zone Area Measurement With Multimodal Imaging in Choroideremia.

Authors:  Yi Zhai; Sarah Oke; Ian M MacDonald
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

6.  Semiautomatic Segmentation of Rim Area Focal Hyperautofluorescence Predicts Progression of Geographic Atrophy Due to Dry Age-Related Macular Degeneration.

Authors:  Michael J Allingham; Qing Nie; Eleonora M Lad; Daniel J Izatt; Priyatham S Mettu; Scott W Cousins; Sina Farsiu
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.